Share on Pinterest Researchers studied if Indigo naturalis affected symptoms of ulcerative colitis. Marcus Chung/Getty Images People with ulcerative colitis who continued taking a Chinese herbal ...

Credit: Getty Images Researchers developed a guide for clinicians to use ozanimod for the treatment of moderate to severe ulcerative colitis. Ulcerative colitis (UC) is a chronic and relapsing type of ...

Researchers have identified a gut-genetic interaction that could trigger an overactive immune response in the colon — offering one possible explanation for the pain and bleeding of ulcerative colitis, ...

Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.

The American Gastroenterological Association has updated guidance for the treatment of ulcerative colitis to recommend using higher efficacy drugs in earlier stages of treatment, Medscape Medical News ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. This is an exciting time to think about ...

Mirikizumab is a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis. Pharmaceutical company Eli Lilly recently released findings of two studies ...

Mirikizumab treatment is safe and efficacious for ulcerative colitis up to 152 weeks in those with and without previous biologic therapy failure. Mirikizumab treatment for 152 weeks is associated with ...

While complementary therapies won’t treat the underlying cause of ulcerative colitis (UC), they can help you manage your symptoms and improve your overall quality of life. Ulcerative colitis (UC) is ...

Roivant Sciences' ulcerative colitis therapy, RVT-3101, shows promising results in Phase 2b trial, attracting interest from major pharmaceutical companies. The company ended the fiscal year with a ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Treatments for ulcerative colitis (UC) are projected to reach $9.6B in eight major markets by 2031 driven by an increase in the patient population and new therapies coming to market. That's the ...